SO
KYNB

STRS Ohio’s Kyntra Bio KYNB Stock Holding History

STRS Ohio’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,684
Closed -$98K – 2006
2024
Q1 		$98K Sell
1,684
-108
-6% -$4.65K ﹤0.01% 1686
2023
Q4 		$39K Hold
1,792
– – ﹤0.01% 1808
2023
Q3 		$38K Hold
1,792
– – ﹤0.01% 1825
2023
Q2 		$120K Buy
1,792
+112
+7% +$46.3K ﹤0.01% 1698
2023
Q1 		$783K Sell
1,680
-340
-17% -$180K ﹤0.01% 1052
2022
Q4 		$809K Sell
2,020
-596
-23% -$228K ﹤0.01% 1031
2022
Q3 		$850K Sell
2,616
-44
-2% -$14.2K ﹤0.01% 994
2022
Q2 		$702K Sell
2,660
-160
-6% -$40.9K ﹤0.01% 1135
2022
Q1 		$847K Buy
2,820
+36
+1% +$12.5K ﹤0.01% 1138
2021
Q4 		$981K Sell
2,784
-352
-11% -$110K ﹤0.01% 1129
2021
Q3 		$801K Buy
3,136
+1,324
+73% +$469K ﹤0.01% 1257
2021
Q2 		$1.21M Buy
1,812
+148
+9% +$85.3K ﹤0.01% 1047
2021
Q1 		$1.44M Buy
1,664
+344
+26% +$366K 0.01% 906
2020
Q4 		$1.22M Buy
1,320
+36
+3% +$37.8K ﹤0.01% 938
2020
Q3 		$1.32M Buy
1,284
+856
+200% +$921K 0.01% 787
2020
Q2 		$433K Buy
428
+160
+60% +$149K ﹤0.01% 1399
2020
Q1 		$232K Sell
268
-92
-26% -$91.5K ﹤0.01% 1510
2019
Q4 		$386K Sell
360
-4,892
-93% -$4.99M ﹤0.01% 1527
2019
Q3 		$4.86M Sell
5,252
-4,700
-47% -$5.16M 0.02% 470
2019
Q2 		$11.2M Buy
9,952
+3,240
+48% +$3.55M 0.05% 338
2019
Q1 		$9.12M Sell
6,712
-1,200
-15% -$1.63M 0.04% 365
2018
Q4 		$9.15M Buy
7,912
+500
+7% +$562K 0.05% 358
2018
Q3 		$11.3M Sell
7,412
-40
-0.5% -$61.6K 0.05% 346
2018
Q2 		$11.7M Buy
7,452
+56
+0.8% +$73K 0.05% 349
2018
Q1 		$8.54M Buy
7,396
+800
+12% +$1.05M 0.04% 374
2017
Q4 		$7.82M Hold
6,596
– – 0.03% 401
2017
Q3 		$8.87M Buy
6,596
+876
+15% +$923K 0.04% 372
2017
Q2 		$4.62M Buy
5,720
+92
+2% +$64.1K 0.02% 494
2017
Q1 		$3.47M Buy
5,628
+4,688
+499% +$2.86M 0.02% 564
2016
Q4 		$502K Hold
940
– – ﹤0.01% 1348
2016
Q3 		$486K Sell
940
-36
-4% -$17K ﹤0.01% 1323
2016
Q2 		$400K Buy
976
+76
+8% +$34.8K ﹤0.01% 1388
2016
Q1 		$479K Buy
900
+48
+6% +$23.9K ﹤0.01% 1281
2015
Q4 		$649K Buy
852
+688
+420% +$457K ﹤0.01% 1117
2015
Q3 		$89K Hold
164
– – ﹤0.01% 1681
2015
Q2 		$96K Buy
164
+40
+32% +$23.3K ﹤0.01% 1687
2015
Q1 		$97K Sell
124
-4
-3% -$3.1K ﹤0.01% 1614
2014
Q4 		$87K Buy
+128
New +$82.4K ﹤0.01% 1555

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

STRS Ohio's KYNB Position: Q2 2024 in Review

STRS Ohio sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 1,684 shares — an estimated $98K sold.

STRS Ohio first reported a position in KYNB in Q4 2014 and held it in 38 quarters. The position peaked at $11.7M in Q2 2018. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • STRS Ohio reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • STRS Ohio sold 1,684 Kyntra Bio shares in Q2 2024, an estimated $98K.
  • STRS Ohio first reported a position in Kyntra Bio in Q4 2014 and held it in 38 quarters.
  • STRS Ohio's Kyntra Bio position peaked at $11.7M in Q2 2018.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on STRS Ohio's 13F filing for Q2 2024, filed 5 Aug 2024.